IL-4Rα Signaling by CD8α Dendritic Cells Contributes to Cerebral Malaria by Enhancing Inflammatory, Th1, and Cytotoxic CD8 T Cell Responses
Overview
Affiliations
Persistent high levels of proinflammatory and Th1 responses contribute to cerebral malaria (CM). Suppression of inflammatory responses and promotion of Th2 responses prevent pathogenesis. IL-4 commonly promotes Th2 responses and inhibits inflammatory and Th1 responses. Therefore, IL-4 is widely considered as a beneficial cytokine via its Th2-promoting role that is predicted to provide protection against severe malaria by inhibiting inflammatory responses. However, IL-4 may also induce inflammatory responses, as the result of IL-4 action depends on the timing and levels of its production and the tissue environment in which it is produced. Recently, we showed that dendritic cells (DCs) produce IL-4 early during malaria infection in response to a parasite protein and that this IL-4 response may contribute to severe malaria. However, the mechanism by which IL-4 produced by DCs contributing to lethal malaria is unknown. Using Plasmodium berghei ANKA-infected C57BL/6 mice, a CM model, we show here that mice lacking IL-4Rα only in CD8α DCs are protected against CM pathogenesis and survive, whereas WT mice develop CM and die. Compared with WT mice, mice lacking IL-4Rα in CD11c or CD8α DCs showed reduced inflammatory responses leading to decreased Th1 and cytotoxic CD8 T cell responses, lower infiltration of CD8 T cells to the brain, and negligible brain pathology. The novel results presented here reveal a paradoxical role of IL-4Rα signaling in CM pathogenesis that promotes CD8α DC-mediated inflammatory responses that generate damaging Th1 and cytotoxic CD8 T cell responses.
Diaba-Nuhoho P BMC Res Notes. 2024; 17(1):328.
PMID: 39482779 PMC: 11529267. DOI: 10.1186/s13104-024-06984-5.
Zainal K, Hasyim A, Yamamoto Y, Mizuno T, Sato Y, Rasyid S Vaccines (Basel). 2024; 12(10).
PMID: 39460322 PMC: 11512279. DOI: 10.3390/vaccines12101155.
Cytokine gene polymorphisms implicated in the pathogenesis of infection outcome.
Segbefia S, Asandem D, Amoah L, Kusi K Front Immunol. 2024; 15:1285411.
PMID: 38404582 PMC: 10884311. DOI: 10.3389/fimmu.2024.1285411.
Varela E, Gomes A, Santos A, de Carvalho E, Vale V, Percario S Nutrients. 2022; 14(24).
PMID: 36558462 PMC: 9787606. DOI: 10.3390/nu14245303.
Cerebral Malaria: Current Clinical and Immunological Aspects.
Albrecht-Schgoer K, Lackner P, Schmutzhard E, Baier G Front Immunol. 2022; 13:863568.
PMID: 35514965 PMC: 9067128. DOI: 10.3389/fimmu.2022.863568.